Clinical Trials
RepliCel's cell therapy products have been tested in the following clinical studies:
Peer-reviewed Papers
RCH-01 for Pattern Baldness
Cell Movement in the Hair Follicle Dermis More Than a Two-Way Street?
Cultured Peribulbar Dermal Sheath Cells Can Induce Hair Follicle Development and Contribute to the D
De Novo Production of Dermal Papilla Cells during the Anagen Phase of the Hair Cycle
Hair Follicle Dermal Stem Cells Regenerate the Dermal Sheath, Repopulate the Dermal Papilla, and Mod
Phase I/IIa clinical trial for the treatment of androgenetic alopecia using intradermal injections of cultured autologous dermal sheath cup cells
Plasticity and Cytokinetic Dynamics of the Hair Follicle Mesenchyme: Implications for Hair Growth Co
RCS-01 for Aging and Sun-damage Skin
Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I Study
RCT-01 for Chronic Achilles Tendinopathy
Skin-Derived Fibroblasts for the Treatment of Refractory Achilles Tendinosis: Preliminary Short-Term
Skin-Derived Tenocyte-like Cells for the Treatment of Patellar Tendinopathy
Treatment of Lateral Epicondylitis Using Skin-Derived Tenocyte-like Cells
Posters
RCH-01 for Pattern Baldness
Towards a Cell-Based Treatment for Androgenetic Alopecia in Men and Women: 12-month Interim Safety R
RCT-01 for Chronic Achilles Tendinopathy
Autologous Cell Treatment for Achilles Tendinosis: A Phase 1/11 Clinical Trial
Clinical Potential of Hair-Follicle Derived Mesenchymal Cells in Cell Therapy: Multiple Therapeutic